DFP-11207

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDFP-11207
Drug Alias NameDFP-11207
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDelta-Fly Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesDelta-Fly Pharma Inc
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A